Year: 2014
Type: dissertation
Abstract: __Abstract__ As defined by World Health Organization (WHO), pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (adverse drug reactions, ADRs). The aims of pharmacovigilance are to improve patient care and patient safety in relation to the use of medicines and to support public health programmes by providing reliable, balanced information on the risk-benefit profile of medicines.
Author: Carmen Ferrajolo
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Università degli Studi di Napoli Federico II, Aarhus Universitet, Aarhus Universitetshospital, University of New South Wales, Università degli Studi di Milano-Bicocca, Università degli Studi di Padova, Seconda Università degli Studi di Napoli, Università degli Studi di Verona, Università degli Studi di Messina, Agenzia Italiana del Farmaco, Ministero della Salute, Erasmus Universitair Medisch Centrum Rotterdam, Janssen Research and Development
OpenAlex ID: W247328092